Table 2.
Young | Middle-age | Old | ||||
---|---|---|---|---|---|---|
| ||||||
Control | Metformin | Control | Metformin | Control | Metformin | |
Latency to initiate walking (s) | 2.13 ± 0.43 | 2.38 ± 0.31 | 3.79 ± 0.47* | 3.48 ± 0.58 | 3.36 ± 0.39 | 4.75 ± 0.56*# |
Latency to turn in a dead-end alley (s) | 8.82 ± 0.60 | 11.01 ± 1.66 | 14.03 ± 2.24 | 10.75 ± 1.34 | 16.56 ± 1.96* | 18.18 ± 2.57* |
Latency to tread (wire suspension) (s) | 20.31 ± 3.55 | 21.75 ± 4.72 | 46.47 ± 4.30* | 44.77 ± 4.35* | 52.33 ± 3.04* | 49.61 ± 2.94* |
Latency to negative geotaxis (s) | 2.39 ± 0.73 | 2.08 ± 0.29 | 2.34 ± 0.63 | 1.74 ± 0.17 | 2.06 ± 0.48 | 2.26 ± 0.25 |
Distance traveled (cm) | 571.9 ± 36.8 | 585.9 ± 30.5 | 526.8 ± 25.9 | 548.9 ± 26.2 | 561.6 ± 34.1 | 624.8 ± 36.3 |
Each value represents the mean ± SE of 15-18 mice.
Significantly different from treatment-matched young, p<0.05
Significantly different from age-matched control, p<0.05